Optimal Human Dose for GII.2 Norovirus (Snow Mountain) Challenge Studies
Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent VLP Vaccine in Children
Human Breastmilk in Young Children With Norovirus Infection of the Gut
Phase 1 Placebo-controlled, Randomized Trial of an Adenoviral-vector Based Norovirus Vaccine
A Multi-Site Clinical Evaluation of the ARIES Norovirus Assay
Efficacy and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-like Particle Vaccine in Adults
NOV120401 (CKD-516 Tablet) for Advanced Solid Tumors
† Study has passed its completion date and status has not been verified in more than two years.